Fingerprint
Dive into the research topics of 'Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
Barbara Drobits, Martin Holcmann, Nicole Amberg, Melissa Swiecki, Roland Grundtner, Martina Hammer, Marco Colonna, Maria Sibilia
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Division of Immunobiology
- Center for Brain Immunology & Glia (BIG)
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- Hope Center for Neurological Disorders
Research output: Contribution to journal › Article › peer-review
250
Scopus
citations